Usefulness of determination of CA-125 in monitoring patients with ovarian carcinoma.
CA-125 was determined in 298 patients with ovarian carcinoma both initially, and during and after treatment. The upper limit of normal for CA-125 in our laboratory is 65 units/ml. Postoperatively, serum CA-125 antigen showed three distinct patterns: 20% of patients in whom levels fluctuate within the normal range have active disease; 100% of patients with fluctuations above 65 U/ml are found to have active disease; 100% of patients in whom levels of CA-125 increase progressively from any nadir, have active disease. An elevated concentration of CA-125 antigen indicates presence of tumor and allows avoidance of 2nd-look surgery. Serum CA-125 antigen fluctuating within the normal range does not indicate eradication of the viable tumor cells.